Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Where To Find High Risk Investments
Identify where to find high risk investments that offer potential for high returns. Explore various avenues to enhance your portfolio.
27,969 articles
Best Artificial Intelligence (AI) ETFs to Invest $2,000 Now
A smart AI investment can kickstart long-term growth. This guide uncovers the best artificial intelligence (ai) ETF f...
Canopy Growth's Stock Just Dropped — Why I Am Not Buying
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...
This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
214% This Year, Late to Buy Micron Stock? Here’s How to Decide
Micron stock has surged as AI memory demand grows. With a gain of 214% this year, late investors wonder if now is the...
Shadow Fleet Illegal Still Moves Through Hormuz Today
Oil shipments remain in flux at the Strait of Hormuz as a pressure-packed crisis persists. The shadow fleet illegal s...
Tesla Stock Gets Wall Street Upgrade on Robotaxi Potential
As robotaxi plans advance, Tesla stock faces a critical test. This article explains why tesla stock gets wall Street ...
Micron’s Dip: Great Chance to Ride the AI Memory Boom
Micron Technology posted strong results, yet the stock slipped. This guide weighs whether micron's dip: great chance ...
Before Nebius Stock, Make Smarter Risk Checks Right Now
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Affirm Klarna: Which Technology Stock Is Better in 2026
As the BNPL market matures, Affirm and Klarna face distinct paths to growth. This guide dives into business models, f...
Lemonade After Morgan Stanley's Upgrade: Is It a Buy?
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status